文献速递中医内科中药与中成药合理使用

木兰花碱经AMPKα介导的脂自噬与脂肪酸氧化改善MASH小鼠

Magnoflorine Ameliorates MASH in Mice Fed a High‐Fat and High‐Fructose Diet by Promoting AMPK‐Mediated Lipophagy and Fatty Acid Oxidation
RSS 订阅 · Phytotherapy Research · 2026-10-27

该研究在高脂高果糖饮食诱导的雄性C57BL/6小鼠MASH模型中评价木兰花碱的作用与机制,并采用HepG2细胞验证。结果显示木兰花碱减轻肝脏脂肪变性、炎症和纤维化,机制依赖AMPKα激活促进肝脂自噬与脂肪酸β氧化;肝特异性沉默AMPKα可阻断其改善作用。

要点

  • 木兰花碱可减轻高脂高果糖饮食小鼠的肝脏脂肪变性、炎症和纤维化。
  • 其作用依赖AMPKα激活,进而促进肝脂自噬和脂肪酸β氧化。
  • 肝特异性沉默AMPKα可阻断木兰花碱对MASH的改善作用。

核心结论

  • 木兰花碱通过AMPKα依赖方式激活肝脂自噬,改善高脂高果糖饮食小鼠的MASH。

研究设计与样本

  • 雄性C57BL/6小鼠接受12周高脂高果糖饮食诱导建立MASH模型,并给予梯度剂量木兰花碱。
  • 研究整合组织病理学(H&E/ORO/Masson)、转录组学及细胞与动物水平的靶向干预。
  • 体外采用棕榈酸孵育的HepG2细胞进行机制验证。

主要发现

  • 木兰花碱有效减轻高脂高果糖饮食小鼠的肝脏脂肪变性、炎症和纤维化。
  • RNA-seq提示AMPK激活是木兰花碱阻碍MASH进展的核心通路。
  • 木兰花碱诱导的AMPKα激活刺激高脂高果糖饮食小鼠肝脂自噬,进而影响脂质β氧化和炎症。
  • 棕榈酸孵育的HepG2细胞结果与动物实验一致。
  • 体外沉默AMPKα可逆转木兰花碱对HepG2细胞脂自噬的促进作用;体内肝特异性沉默AMPKα可阻断木兰花碱增强肝脂自噬及改善MASH的效应。

临床怎么用

  • 木兰花碱作为天然季铵阿朴啡类生物碱,为MASH提供了新的潜在治疗候选,但当前证据仅来自小鼠与HepG2细胞,尚需临床研究验证。

局限性

  • 研究仅使用雄性C57BL/6小鼠与HepG2细胞,未涉及人体或临床结局。
  • 原文摘要未报告具体剂量、样本量及统计值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Magnoflorine ameliorates metabolic dysfunction-associated steatohepatitis by promoting AMPKα-mediated lipophagy and fatty acid oxidation. ABSTRACT Emerging as a significant clinical burden, metabolic dysfunction-associated steatohepatitis (MASH) continues to challenge global healthcare systems due to limited effective interventions. Magnoflorine, a naturally occurring quaternary aporphine alkaloid abundant in dietary botanicals, has demonstrated promising hypolipidemic and anti-inflammatory properties in preliminary investigations. This investigation systematically evaluated both the therapeutic potential and mechanistic pathways underlying the capacity of magnoflorine to ameliorate MASH-associated hepatic pathologies. Male C57BL/6 mice received 12-week high-fat and high-fructose diet (HFFD) induction to establish MASH models, with graded magnoflorine dosing. Through integrated histopathology (H&E/ORO/Masson), transcriptomics, and targeted interventions at both cellular and animal levels, we elucidated the therapeutic mechanisms of magnoflorine. Results showed that magnoflorine effectively alleviated hepatic steatosis, inflammation, and fibrosis in HFFD-fed mice. Mechanistically, RNA-seq revealed that the 5′-monophosphate AMP-activated protein kinase (AMPK) activation was the central pathway mediating the effects of magnoflorine to impede MASH progression. Furthermore, AMPKα activation induced by magnoflorine stimulated hepatic lipophagy in HFFD-fed mice, which further affected lipid β-oxidation and inflammation. The findings were consistent in HepG2 cells incubated with palmitic acid. In vitro, silencing AMPKα reversed the stimulatory effect of magnoflorine on lipophagy in HepG2 cells. In vivo, liver-specific AMPKα silencing in mice blocked the enhancement of hepatic lipophagy and the improvement of MASH caused by magnoflorine. In brief, this study indicates that magnoflorine improves MASH in mice by activating hepatic lipophagy via AMPKα-dependent effects. This discovery provides a novel potential therapeutic alternative for MASH.

来源:Phytotherapy Research,查看原文。版权归原作者所有。

引用

  1. Phytotherapy Research:Magnoflorine Ameliorates MASH in Mice Fed a High‐Fat and High‐Fructose Diet by Promoting AMPK‐Mediated Lipophagy and Fatty Acid Oxidation

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。